Get the Stockscreener App
31.06
4.30%
1.28
After Hours:
30.82
-0.24
-0.77%
ARK Genomic Revolution ETF stock is traded at $31.06, with a volume of 1.81M.
It is up +4.30% in the last 24 hours and up +13.94% over the past month.
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
See More
Previous Close:
$29.78
Open:
$29.95
24h Volume:
1.81M
Relative Volume:
0.69
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+8.87%
1M Performance:
+13.94%
6M Performance:
+9.52%
1Y Performance:
+52.70%
1-Day Range:
$29.57
$31.11
1-Week Range:
$28.61
$31.11
52-Week Range:
$20.25
$34.39
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Name
ARK Genomic Revolution ETF
Sector
Industry
Phone
855-406-1506
Address
-
Compare ARKG vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
31.06 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
361.86 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
733.83 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
737.41 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
290.85 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
695.77 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF Stock (ARKG) Latest News
The Technical Signals Behind (ARKG) That Institutions Follow - Stock Traders Daily
Cathie Wood buys tumbling Robinhood stock, ARK adds $30 mil of this stock - MSN
Cathie Wood's Ark bets on Google, Meta and CoreWeave; cuts AMD and Bitcoin ETF (ARKK:BATS) - Seeking Alpha
Cathie Wood's Ark Invest buys proteomics company Alamar, Netflix; trims crypto names - MSN
Cathie Wood's ARK bets bigger on this biotech play, slashes stake in this space stock - MSN
Cathie Wood Buys Tumbling Robinhood Stock, ARK Adds $30 Mil Of This Stock - Investor's Business Daily
Cathie Wood Offloads Rocket Lab Stock (RKLB) Despite 3% Jump, Buys the Dip in Intellia (NTLA) - TipRanks
Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names - MSN
Cathie Wood Makes $14M Bet on Alphabet Stock Ahead of Today’s Q1 Earnings, Buys the Dip in CRWV and Trims Bullish Stake - TipRanks
Cathie Wood’s ARK saw SpaceX IPO as bet on space economy - MSN
More NTLA, Less RKLB: Cathie Wood’s Latest ARK Trades Explained - Stocktwits
Cathie Wood's Ark Invest weekly recap: adds Chinese tech names, Intellia Therapeutics - MSN
Cathie Wood’s once upon a time $1,500 Zoom call by 2026 meets reality as software struggles - MSN
Cathie Wood buys $2 million of tumbling AI stock - MSN
🚀 Cathie Wood Says Teladoc Stock (TDOC) Will 10XHere's Why (XcSe6nD70v) - Fathom Journal
Cathie Woods' Ark Invest weekly recap: lifts stake in Bullish and Brera, trims Roku and Tempus AI - msn.com
Full Cathie Wood Portfolio[All 7 ARK Invest ETFs] (i7gIwmd67A) - Fathom Journal
Precision Trading with Ark Genomic Revolution Etf (ARKG) Risk Zones - Stock Traders Daily
Cathie Wood buys the Netflix dip as shares slide on WBD deal jitters - MSN
Cathie Wood's weekly recap: heads turn to AI, biotech; sells communication names - MSN
Trending Industry Today: ARK Genomic Revolution ETF Leads Losses In ARK ETFs Stocks - 富途牛牛
🧬 DNA Stock | Is Ginkgo Bioworks The Next Amazon Stock? (D5ecHEip1a) - fathomjournal.org
Cathie Wood Is Buying Up Alamar Biosciences Stock After Its IPO. Should You Snag Proteomics-Focused ALMR Too? - Barchart.com
Cathie Wood slams the brakes — Ark Invest sits out as S&P 500 smashes records - MSN
Cathie Wood Slams The Brakes — Ark Invest Sits Out As S&P 500 Smashes Records - Sahm
ARK Genomic Revolution ETF Stock (ARKG) Financials Data
There is no financial data for ARK Genomic Revolution ETF (ARKG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.69%
Cap:
|
Volume (24h):